Structure-activity relationship for the folding intermediate-selective inhibition of DYRK1A

被引:6
|
作者
Miyazaki, Yuka [1 ]
Kikuchi, Masaki [2 ]
Umezawa, Koji [3 ]
Descamps, Aurelie [4 ]
Nakamura, Daichi [4 ]
Furuie, Gaku [1 ]
Sumida, Tomoe [4 ,6 ]
Saito, Kanako [1 ]
Kimura, Ninako [1 ]
Niwa, Takashi [4 ]
Sumida, Yuto [4 ,6 ]
Umehara, Takashi [2 ]
Hosoya, Takamitsu [4 ,5 ]
Kii, Isao [1 ,3 ,4 ]
机构
[1] Shinshu Univ, Grad Sch Sci & Technol, Dept Agr, Lab Drug Target Res, 8304 Minami Minowa, Nagano 3994598, Japan
[2] RIKEN, Lab Epigenet Drug Discovery, Ctr Biosyst Dynam Res, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan
[3] Shinshu Univ, Inst Biomed Sci, Dept Biomol Innovat, 8304 Minami Minowa, Nagano 3994598, Japan
[4] RIKEN, Lab Chem Biol, Ctr Biosyst Dynam Res, Chuo Ku, 6-7-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan
[5] Tokyo Med & Dent Univ TMDU, Inst Biomat & Bioengn, Lab Chem Biosci, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo, Japan
[6] Kanazawa Univ, Grad Sch Med Sci, Div Pharmaceut Sci, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan
关键词
DYRK1A; Folding intermediate; Autophosphorylation; FINDY; Alzheimer's disease; Down syndrome; DOWN-SYNDROME CANDIDATE; PROTEIN-KINASE; MOUSE MODEL; MURINE MODEL; DRUG-TARGET; CYCLIN D1; ACTIVATION; AUTOPHOSPHORYLATION; OVEREXPRESSION; REVEALS;
D O I
10.1016/j.ejmech.2021.113948
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
DYRK1A phosphorylates proteins involved in neurological disorders in an intermolecular manner. Meanwhile, during the protein folding process of DYRK1A, a transitional folding intermediate catalyzes the intramolecular autophosphorylation required for the "one-off" inceptive activation and stabilization. In our previous study, a small molecule termed FINDY (1) was identified, which inhibits the folding intermediate-catalyzed intramolecular autophosphorylation of DYRK1A but not the folded state-catalyzed intermolecular phosphorylation. However, the structural features of FINDY (1) responsible for this intermediate-selective inhibition remain elusive. In this study, structural derivatives of FINDY (1) were designed and synthesized according to its predicted binding mode in the ATP pocket of DYRK1A. Quantitative structure-activity relationship (QSAR) of the derivatives revealed that the selectivity against the folding intermediate is determined by steric hindrance between the bulky hydrophobic moiety of the derivatives and the entrance to the pocket. In addition, a potent derivative 3 was identified, which inhibited the folding intermediate more strongly than FINDY (1); it was designated as dp-FINDY. Although dp-FINDY (3) did not inhibit the folded state, as well as FINDY (1), it inhibited the intramolecular autophosphorylation of DYRK1A in an in vitro cell-free protein synthesis assay. Furthermore, dp-FINDY (3) destabilized endogenous DYRK1A in HEK293 cells. This study provides structural insights into the folding intermediate-selective inhibition of DYRK1A and expands the chemical options for the design of a kinase inhibitor. (C) 2021 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Expression and purification of DYRK1A kinase domain in complex with its folding intermediate-selective inhibitor FINDY
    Kimura, Ninako
    Saito, Kanako
    Niwa, Takashi
    Yamakawa, Masato
    Igaue, Shota
    Ohkanda, Junko
    Hosoya, Takamitsu
    Kii, Isao
    PROTEIN EXPRESSION AND PURIFICATION, 2022, 195
  • [2] Selective inhibition of the kinase DYRK1A by targeting its folding process
    Kii, Isao
    Sumida, Yuto
    Goto, Toshiyasu
    Sonamoto, Rie
    Okuno, Yukiko
    Yoshida, Suguru
    Kato-Sumida, Tomoe
    Koike, Yuka
    Abe, Minako
    Nonaka, Yosuke
    Ikura, Teikichi
    Ito, Nobutoshi
    Shibuya, Hiroshi
    Hosoya, Takamitsu
    Hagiwara, Masatoshi
    NATURE COMMUNICATIONS, 2016, 7
  • [3] Activation, regulation, and inhibition of DYRK1A
    Becker, Walter
    Sippl, Wolfgang
    FEBS JOURNAL, 2011, 278 (02) : 246 - 256
  • [4] Function and inhibition of DYRK1A: Emerging roles of treating multiple human diseases
    Yang, Yuping
    Fan, Xiaoxiao
    Liu, Yongjian
    Ye, Danyang
    Liu, Cen
    Yang, Hongliu
    Su, Zhijun
    Zhang, Yuanyuan
    Liu, Yonggang
    BIOCHEMICAL PHARMACOLOGY, 2023, 212
  • [5] DYRK1A and cognition: A lifelong relationship
    Arbones, Maria L.
    Thomazeau, Aurore
    Nakano-Kobayashi, Akiko
    Hagiwara, Masatoshi
    Delabar, Jean M.
    PHARMACOLOGY & THERAPEUTICS, 2019, 194 : 199 - 221
  • [6] Identification and analysis of a selective DYRK1A inhibitor
    Lin, Tony Eight
    Chao, Min-Wu
    HuangFu, Wei-Chun
    Tu, Huang-Ju
    Peng, Zhao-Xiang
    Su, Chih-Jou
    Sung, Tzu-Ying
    Hsieh, Jui-Hua
    Lee, Cheng-Chung
    Yang, Chia-Ron
    Pan, Shiow-Lin
    Hsu, Kai-Cheng
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 146
  • [7] DYRK1A inhibition as potential treatment for Alzheimer's disease
    Stotani, Silvia
    Giordanetto, Fabrizio
    Medda, Federico
    FUTURE MEDICINAL CHEMISTRY, 2016, 8 (06) : 681 - 696
  • [8] Inhibition of DYRK1A and GSK3B induces human β-cell proliferation
    Shen, Weijun
    Taylor, Brandon
    Jin, Qihui
    Nguyen-Tran, Van
    Meeusen, Shelly
    Zhang, You-Qing
    Kamireddy, Anwesh
    Swafford, Austin
    Powers, Andrew F.
    Walker, John
    Lamb, John
    Bursalaya, Badry
    DiDonato, Michael
    Harb, George
    Qiu, Minhua
    Filippi, Christophe M.
    Deaton, Lisa
    Turk, Carolina N.
    Suarez-Pinzon, Wilma L.
    Liu, Yahu
    Hao, Xueshi
    Mo, Tingting
    Yan, Shanshan
    Li, Jing
    Herman, Ann E.
    Hering, Bernhard J.
    Wu, Tom
    Seidel, H. Martin
    McNamara, Peter
    Glynne, Richard
    Laffitte, Bryan
    NATURE COMMUNICATIONS, 2015, 6
  • [9] Mining Public Domain Data to Develop Selective DYRK1A Inhibitors
    Henderson, Scott H.
    Sorrell, Fiona
    Bennett, James
    Hanley, Marcus T.
    Robinson, Sean
    Navratilova, Iva Hopkins
    Elkins, Jonathan M.
    Ward, Simon E.
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (08): : 1620 - 1626
  • [10] Inhibition of DYRK1A Stimulates Human β-Cell Proliferation
    Dirice, Ercument
    Walpita, Deepika
    Vetere, Amedeo
    Meier, Bennett C.
    Kahraman, Sevim
    Hu, Jiang
    Dancik, Vlado
    Burns, Sean M.
    Gilbert, Tamara J.
    Olson, David E.
    Clemons, Paul A.
    Kulkarni, Rohit N.
    Wagner, Bridget K.
    DIABETES, 2016, 65 (06) : 1660 - 1671